Clinical Trial Update: MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study [Phase 2]

View source ↗

Summary

A long-term safety study report for MRX-800 (maralixibat) in cholestatic liver disease, including participants who previously took part in a maralixibat trial, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Disease

Drugs mentioned

• MRX-800 (maralixibat) (maralixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Cholestatic Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-12-08